Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lindsay A Md Rosenwald is PRESIDENT, CEO & CHAIRMAN at Journey Medical. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 26, 2026, each linked to the official Form 4.
PRESIDENT, CEO & CHAIRMAN
Disclosures on record
1
Companies involved
1
Lindsay A Md Rosenwald bought shares on the open market in 12 different years since 2011, and has not bought since 2024 across 3 companies.
Lindsay A Md Rosenwald reported 42 open-market purchases and 0 sales since 2011; purchases in 12 different years, most recently 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $1.78M9×9 trades | — |
| 2023 | $5.14M6×6 trades | — |
| 2022 | $146K5×5 trades | — |
| 2020 | $1.21M2×2 trades | — |
| 2019 | $3.9K2×2 trades | — |
| 2018 | $221K1×1 trade | — |
| 2017 | $1M1×1 trade | — |
| 2016 | $3K2×2 trades | — |
| 2015 | $2.8K2×2 trades | — |
| 2014 | $243K2×2 trades | — |
| 2012 | $1.09M9×9 trades | — |
| 2011 | $14K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Journey MedicalDERM
Jun 25, 202610Kdisclosed Jun 26
DetailsOfficial recordLindsay A Md Rosenwald reported 35 open-market purchases and 0 sales here, 2011 to 2024.
Lindsay A Md Rosenwald reported 4 open-market purchases and 0 sales here, 2018 to 2022.
Lindsay A Md Rosenwald reported 3 open-market purchases and 0 sales here, 2023 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Lindsay A Md Rosenwald reported holding 4,586,841 shares of Fortress Biotech (FBIO), worth about $8.35M at the last close of $2 (Nov 17, 2026). Holdings are also on file at Journey Medical (DERM); together they are worth about $9.21M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Fortress Biotech FBIO | 4,586,841 | 4.59M direct | $2 | $8.35M | Mar 18, 2026 |
| Journey Medical DERM | 221,146 | 221K direct | $4 | $862K | Jun 25, 2026 |
Is this Lindsay A Md Rosenwald’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Mar 18, 2026, Lindsay A Md Rosenwald reported holding 4,586,841 shares of Fortress Biotech (FBIO). At the last close of $2 on Nov 17, 2026, that is about $8.35M. This is the stake disclosed in filings, not a net worth.
Lindsay A Md Rosenwald bought shares on the open market in 12 different years since 2011, and has not bought since 2024 across 3 companies.
In SEC filings since 2011: the latest open-market purchase is from 2024; no open-market sale is on record.
3 companies: Fortress Biotech (FBIO, 2011–2024), Journey Medical (DERM, 2023–2024), Mustang Bio (MBIO, 2018–2022).